Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2011 by University Hospital Freiburg.
Recruitment status was  Recruiting
Sponsor:
Collaborators:
Wako Diagnostics
Johannes Gutenberg University Mainz
University Hospital Heidelberg
Information provided by (Responsible Party):
Dominik Bettinger, University Hospital Freiburg
ClinicalTrials.gov Identifier:
NCT01361061
First received: May 16, 2011
Last updated: December 14, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)